Acadian Asset Management’s Astria Therapeutics ATXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,411
| Closed | -$26K | – | 1640 |
|
|
2024
Q3 | $26K | Buy |
+2,411
| New | +$26K | ﹤0.01% | 1935 |
|
|
2023
Q1 | – | Sell |
-23,429
| Closed | -$348K | – | 1740 |
|
|
2022
Q4 | $348K | Buy |
23,429
+11,968
| +104% | +$178K | ﹤0.01% | 1138 |
|
|
2022
Q3 | $103K | Buy |
+11,461
| New | +$103K | ﹤0.01% | 1355 |
|
|
2021
Q1 | – | Sell |
-1,960
| Closed | -$25K | – | 2053 |
|
|
2020
Q4 | $25K | Buy |
+1,960
| New | +$25K | ﹤0.01% | 2108 |
|
|
2019
Q2 | – | Sell |
-487
| Closed | -$23K | – | 1785 |
|
|
2019
Q1 | $23K | Buy |
+487
| New | +$23K | ﹤0.01% | 1796 |
|
|
2018
Q1 | – | Sell |
-272
| Closed | -$24K | – | 1675 |
|
|
2017
Q4 | $24K | Buy |
+272
| New | +$24K | ﹤0.01% | 1340 |
|
|
2017
Q3 | – | Sell |
-254
| Closed | -$21K | – | 1401 |
|
|
2017
Q2 | $21K | Buy |
+254
| New | +$21K | ﹤0.01% | 1245 |
|